Efficacy and Safety of Insulin Aspart Versus Glibenclamide in Type 2 Diabetes
Clinical trial NCT00267683 · TERMINATED
Trial details
- NCT number
- NCT00267683
- Sponsor
- Novo Nordisk A/S
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-12-01
- Primary completion
- 2006-04-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.